Diuretics, mode of action in the kidney;Angriffspunkte der diuretika in der niere

Therapeutische Umschau

Volumn 57, Issue 6, 2000, Pages 345-350

  Ferrari, P ^a   Frey, F J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ALDACTON; AMILORIDE; BUMETANIDE; CARBONATE DEHYDRATASE INHIBITOR; CHLORTALIDONE; FUROSEMIDE; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LOOP DIURETIC AGENT; METOLAZONE; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TORASEMIDE;

DIURESIS; DRUG MECHANISM; ELECTROLYTE TRANSPORT; HOMEOSTASIS; HUMAN; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE EXCRETION; REVIEW;

EID: 0033917084     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.57.6.345     Document Type: Review

References (24)

1. Donnell GN, Litman N, Roldan M. Pseudohypo-adrenocorticism: renal sodium loss, hyponatremia and hyperkalemia due to a renal tubular insensitivity to mineralocorticoids. Am J Dis Child 1959; 97: 813.
2. Bartter FC, Pronove P, Gill JR, Jr, MacCardle RC. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis: a new syndrome. Am J Med 1962; 33: 811.
3. Gitelman HJ, Graham JB, Welt LG. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians 1966; 79: 221.
4. Guibaud P, Larbre F, Freycon MT, Genoud J. Osteopetrose et acidose renale tubulaire. Deux cas de cette association dans une fratrie. Arch Fr Pediatr 1972; 29: 269.
5. Simon DB, Nelson-Williams C, Bia MJ, et al. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 1996; 12: 24.
6. Simon DB, Karet FE, Hamdan JM, et al. Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet 1996; 13: 183.
7. Chang SS, Grunder S, Hanukoglu A, et al. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat Genet 1996; 12: 248.
8. Geller DS, Rodriguez-Soriano J, Vallo Boado A, et al.: Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I. Nat Genet 1998; 19: 279.
9. Tashian RE. Genetics of the mammalian carbonic anhydrases. Adv Genet 1992; 30: 321.
10. Sly WS, Hu PY. Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu Rev Biochem 1995; 64: 375.
11. Lonnerholm G, Wistrand PJ. Carbonic anhydrase in the human kidney: a histochemical and immunocytochemical study. Kidney Int 1984; 25: 886.
12. Kim J, Tisher CC, Linser PJ, Madsen KM. Ultrastructural localization of carbonic anhydrase II in subpopulations of intercalated cells of the rat kidney. J Am Soc Nephrol 1990; 1: 245.
13. Whyte MP, Murphy WA, Fallon MD, et al. Osteopetrosis, renal tubular acidosis and basal ganglia calcification in three sisters. Am J Med 1980; 69: 64.
14. Fathallah DM, Bejaoui M, Sly WS, Lakhoua R, Dellagi K. A unique mutation underlying carbonic anhydrase II deficiency syndrome in patients of Arab descent. Hum Genet 1994; 94: 581.
15. Hu P., Lim EJ, Ciccolella J, Strisciuglio P, Sly WS. Seven novel mutations in carbonic anhydrase II deficiency syndrome identified by SSCP and direct sequencing analysis. Hum Mutat 1997; 9: 383.
16. Aronson PS. Role of ion exchangers in mediating NaCl transport in the proximal tubule. Kidney Int 1996; 49: 1665.
17. Hebert SC. Roles of Na-K-2Cl and Na-Cl cotransporters and ROMK potassium channels in urinary concentrating mechanism. Am J Physiol 1998; 275: F325.
18. Stahl MM, Vaara I. Gitelman versus classic Bartter syndrome. J Pediatr 1993; 123: 671.
19. Lifton RP, Dluhy RG, Powers M, et al. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992; 355: 262.
20. Ulick S, Levine LS, Gunczler P, et al. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metab 1979; 49: 757.
21. Wilson RC, Krozowski ZS, Li K, et al. A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab 1995; 80: 2263.
22. Ferrari P, Obeyesekere VR, Li K, et al. Point mutations abolish 11 beta-hydroxysteroid dehydrogenase type II activity in three families with the congenital syndrome of apparent mineralocorticoid excess. Mol Cell Endocrinol 1996; 119: 21.
23. Liddle GW, Bledsoe T, Coppage WSJ. A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Trans Am Assoc Physicians 1963; 76: 199.
24. Shimkets RA, Warnock DG, Bositis CM, et al. Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 1994; 79: 407.